No insider purchase over the last 90 days. The latest was filed 01 Mar 2021.
This page follows insider dealings at NattoPharma ASA as filed with Oslo Børs, a company from the Health Care sector. No insider at NattoPharma ASA has published a filing in the past twelve months. The most recent one dates from 29 March 2021.
Other companies in the same sector with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
· cache
NattoPharma ASA is a Norwegian company focused on the development and marketing of health products based on vitamin K2. It is listed on the Oslo Stock Exchange.